A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
Clinical trial NCT01988961 · COMPLETED
Trial details
- NCT number
- NCT01988961
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-01
- Primary completion
- 2015-02-01
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.